A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Status unconfirmed · Phase 2/Phase 3

Conditions studied: Irritable Bowel Syndrome

In brief

This study will evaluate the safety and effectiveness of the investigational drug DDP733 in treating female patients with IBS-c. A placebo control will be utilized.

Key facts

Study ID
NCT00547469
Run by
Dynogen Pharmaceuticals
People needed
360
Starts
2007-10-01
Last updated by the study team
2008-04-08

Who can join

Age: 18 and older, up to 65. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.